Search Results
Search for other papers by Pamela Brock in
Google Scholar
PubMed
Search for other papers by Jennifer L Geurts in
Google Scholar
PubMed
Search for other papers by Paulien Van Galen in
Google Scholar
PubMed
Search for other papers by Erica Blouch in
Google Scholar
PubMed
Search for other papers by James Welch in
Google Scholar
PubMed
Search for other papers by Amy Kunz in
Google Scholar
PubMed
Search for other papers by Lauren Desrosiers in
Google Scholar
PubMed
Search for other papers by Jennifer Gauerke in
Google Scholar
PubMed
Search for other papers by Samuel Hyde in
Google Scholar
PubMed
evaluate the clinical validity of gene-disease relationships, for which an evidence-based framework has been published and a hereditary cancer working group convened that has already curated many HEN genes, including the SDHx genes, MAX , TMEM127 , CDC
Search for other papers by Rodrigo A Toledo in
Google Scholar
PubMed
Search for other papers by Roxanne Hatakana in
Google Scholar
PubMed
Search for other papers by Delmar M Lourenço Jr in
Google Scholar
PubMed
Search for other papers by Susan C Lindsey in
Google Scholar
PubMed
Search for other papers by Cleber P Camacho in
Google Scholar
PubMed
Search for other papers by Marcio Almeida in
Google Scholar
PubMed
Search for other papers by José V Lima Jr in
Google Scholar
PubMed
Search for other papers by Tomoko Sekiya in
Google Scholar
PubMed
Search for other papers by Elena Garralda in
Google Scholar
PubMed
Search for other papers by Michel S Naslavsky in
Google Scholar
PubMed
Search for other papers by Guilherme L Yamamoto in
Google Scholar
PubMed
Search for other papers by Monize Lazar in
Google Scholar
PubMed
Search for other papers by Osorio Meirelles in
Google Scholar
PubMed
Search for other papers by Tiago J P Sobreira in
Google Scholar
PubMed
Search for other papers by Maria Lucia Lebrao in
Google Scholar
PubMed
Search for other papers by Yeda A O Duarte in
Google Scholar
PubMed
Search for other papers by John Blangero in
Google Scholar
PubMed
Search for other papers by Mayana Zatz in
Google Scholar
PubMed
Search for other papers by Janete M Cerutti in
Google Scholar
PubMed
Search for other papers by Rui M B Maciel in
Google Scholar
PubMed
Endocrine Genetics Unit (Laboratório de Investigação Médica/LIM-25) of Hospital das Clínicas, Nursing School, School of Public Health, Human Genome Research Center, Division of Genetics, Division of Endocrinology, Brazilian National Laboratory of Biosciences, Centro Integral Oncológico Clara Campal, Department of Genetics, Endocrinology Division, Laboratory of Epidemiology and Population Sciences, University of São Paulo School of Medicine, São Paulo, São Paulo 05403-010, Brazil
Search for other papers by Sergio P A Toledo in
Google Scholar
PubMed
. Phaeochromocytoma patients initially reported to be RET Y791F-only carriers can harbour variants of other genes, e.g. VHL or SDHx , that are most probably the cause of the disease. Lesson from finding 4: Established clinical predictors and algorithms should be
Search for other papers by Erwan Thouënnon in
Google Scholar
PubMed
Search for other papers by Alice Pierre in
Google Scholar
PubMed
Search for other papers by Yannick Tanguy in
Google Scholar
PubMed
Search for other papers by Johann Guillemot in
Google Scholar
PubMed
Search for other papers by Destiny-Love Manecka in
Google Scholar
PubMed
Search for other papers by Marlène Guérin in
Google Scholar
PubMed
Search for other papers by L'houcine Ouafik in
Google Scholar
PubMed
Search for other papers by Mihaela Muresan in
Google Scholar
PubMed
Search for other papers by Marc Klein in
Google Scholar
PubMed
Search for other papers by Jérôme Bertherat in
Google Scholar
PubMed
Search for other papers by Hervé Lefebvre in
Google Scholar
PubMed
Search for other papers by Pierre-François Plouin in
Google Scholar
PubMed
Search for other papers by Laurent Yon in
Google Scholar
PubMed
Search for other papers by Youssef Anouar in
Google Scholar
PubMed
Endocrinology and Metabolism 92 4865 – 4872 . Timmers H Gimenez-Roqueplo AP Mannelli M Pacak K 2009 Clinical aspects of SDHx-related pheochromocytoma and paraganglioma . Endocrine-Related Cancer 16 391 – 400 . Turquier V Yon L Grumolato
Search for other papers by Giulia Vocino Trucco in
Google Scholar
PubMed
Search for other papers by Marco Volante in
Google Scholar
PubMed
immunohistochemistry may be used also as a complement to genetic testing. For example, in paragangliomas, loss of SDHB expression serves as a surrogate biomarker for SDHx alterations (such as germline mutations in SDHA , SDHB , SDHC , SDHD , and SDHAF2
Search for other papers by Fredrika Svahn in
Google Scholar
PubMed
Search for other papers by Karolina Solhusløkk Höse in
Google Scholar
PubMed
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Department of Breast, Endocrine Tumors and Sarcoma, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Adam Stenman in
Google Scholar
PubMed
Department of Breast Surgery, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China
Search for other papers by Yaxuan Liu in
Google Scholar
PubMed
Search for other papers by Jan Calissendorff in
Google Scholar
PubMed
Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Emma Tham in
Google Scholar
PubMed
Search for other papers by Ákos Végvári in
Google Scholar
PubMed
Search for other papers by Roman A Zubarev in
Google Scholar
PubMed
Department of Medicine Huddinge, Karolinska Institutet, Huddinge, Sweden
Search for other papers by Na Wang in
Google Scholar
PubMed
Search for other papers by Reju Korah in
Google Scholar
PubMed
Carling Adrenal Center, Tampa, Florida, USA
Search for other papers by Tobias Carling in
Google Scholar
PubMed
Department of Breast, Endocrine Tumors and Sarcoma, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Jan Zedenius in
Google Scholar
PubMed
Department of Breast, Endocrine Tumors and Sarcoma, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Robert Bränström in
Google Scholar
PubMed
Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital Stockholm, Sweden
Search for other papers by C Christofer Juhlin in
Google Scholar
PubMed
Search for other papers by Catharina Larsson in
Google Scholar
PubMed
status and/or mRNA expression profile, tumors were assigned as cluster 1 ( SDHx , VHL , EPAS1, and EGLN1 ) or cluster 2 ( RET , NF1 , TMEM127 , MAX , and HRAS ). Fresh frozen tumor tissue samples were collected from the local Biobank for all 97
Search for other papers by Anna Angelousi in
Google Scholar
PubMed
Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed
Search for other papers by Georgios Zografos in
Google Scholar
PubMed
Search for other papers by Svenja Nölting in
Google Scholar
PubMed
Division of Translational and Experimental Medicine, University of Warwick Medical School, Clinical Sciences Research Laboratories, Coventry, UK
Department of Endocrinology, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, University of Oxford, Oxford, UK
Search for other papers by Gregory Kaltsas in
Google Scholar
PubMed
Search for other papers by Ashley Grossman in
Google Scholar
PubMed
studies have identified two main activated molecular pathways leading to the development of these tumours: the hypoxic (cluster-1 genes), mainly involving the succinate dehydrogenase ( SDHx ) and the Von Hippel-Lindau ( VHL ) genes, and the mTOR (cluster-2
Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
Search for other papers by Samantha Peiling Yang in
Google Scholar
PubMed
Oncology Academic Clinical Program, Duke-NUS Medical School, Singapore, Singapore
Search for other papers by Joanne Ngeow in
Google Scholar
PubMed
Eng C 2012 Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53 . Human Molecular Genetics 21 300 – 310 . ( doi:10.1093/hmg/ddr459 ) Orloff MS He
Search for other papers by Jan P Dumanski in
Google Scholar
PubMed
Search for other papers by Chiara Rasi in
Google Scholar
PubMed
Search for other papers by Peyman Björklund in
Google Scholar
PubMed
Search for other papers by Hanna Davies in
Google Scholar
PubMed
Search for other papers by Abir S Ali in
Google Scholar
PubMed
Search for other papers by Malin Grönberg in
Google Scholar
PubMed
Search for other papers by Staffan Welin in
Google Scholar
PubMed
Department of Clinical Science, University of Bergen, Bergen, Norway
Search for other papers by Halfdan Sorbye in
Google Scholar
PubMed
Search for other papers by Henning Grønbæk in
Google Scholar
PubMed
Search for other papers by Janet L Cunningham in
Google Scholar
PubMed
Search for other papers by Lars A Forsberg in
Google Scholar
PubMed
Search for other papers by Lars Lind in
Google Scholar
PubMed
Search for other papers by Erik Ingelsson in
Google Scholar
PubMed
Search for other papers by Peter Stålberg in
Google Scholar
PubMed
Search for other papers by Per Hellman in
Google Scholar
PubMed
Search for other papers by Eva Tiensuu Janson in
Google Scholar
PubMed
are not enriched in frequency among all SI-NET patients, when compared to the control population. Furthermore, mutations in the SDHx genes have previously been implicated in cancer, and particularly, in forms related to SI-NETs, such as
Search for other papers by Camilo Jimenez in
Google Scholar
PubMed
Search for other papers by Sasan Fazeli in
Google Scholar
PubMed
Department of Endocrinology, Hospital Universitario San Vicente Fundacion, Medellin, Colombia
Search for other papers by Alejandro Román-Gonzalez in
Google Scholar
PubMed
mTORC1 complex is significantly overactivated in SDHX-mutated paragangliomas . Neuroendocrinology 105 384 – 393 . ( https://doi.org/10.1159/000455864 ) Parikh PP Rubio GA Farra JC Lew JI 2017 Nationwide review of hormonally active
Search for other papers by Katharina Wang in
Google Scholar
PubMed
Search for other papers by Ina Schütze in
Google Scholar
PubMed
Search for other papers by Sebastian Gulde in
Google Scholar
PubMed
Department of Internal Medicine III, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany
Search for other papers by Nicole Bechmann in
Google Scholar
PubMed
Search for other papers by Susan Richter in
Google Scholar
PubMed
Search for other papers by Jana Helm in
Google Scholar
PubMed
Search for other papers by Michael Lauseker in
Google Scholar
PubMed
Search for other papers by Julian Maurer in
Google Scholar
PubMed
Search for other papers by Astrid Reul in
Google Scholar
PubMed
Search for other papers by Gerald Spoettl in
Google Scholar
PubMed
National Center of Genetics, Laboratoire National de Santé, Dudelange, Luxembourg
German Cancer Consortium, Dresden, Germany
Search for other papers by Barbara Klink in
Google Scholar
PubMed
Search for other papers by Doreen William in
Google Scholar
PubMed
Search for other papers by Thomas Knösel in
Google Scholar
PubMed
Search for other papers by Juliane Friemel in
Google Scholar
PubMed
Search for other papers by Michel Bihl in
Google Scholar
PubMed
Search for other papers by Achim Weber in
Google Scholar
PubMed
Search for other papers by Maria Fankhauser in
Google Scholar
PubMed
Search for other papers by Laura Schober in
Google Scholar
PubMed
Search for other papers by Diana Vetter in
Google Scholar
PubMed
Search for other papers by Martina Broglie Däppen in
Google Scholar
PubMed
Search for other papers by Christian G Ziegler in
Google Scholar
PubMed
Search for other papers by Martin Ullrich in
Google Scholar
PubMed
Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, Dresden, Germany
Search for other papers by Jens Pietzsch in
Google Scholar
PubMed
Search for other papers by Stefan R Bornstein in
Google Scholar
PubMed
Search for other papers by Christian Lottspeich in
Google Scholar
PubMed
Division of Endocrinology and Diabetes, Department of Medicine I, University Hospital Würzburg, University of Würzburg, Würzburg, Germany
Search for other papers by Matthias Kroiss in
Google Scholar
PubMed
Search for other papers by Martin Fassnacht in
Google Scholar
PubMed
Search for other papers by Vera Ursula Julia Wenter in
Google Scholar
PubMed
Search for other papers by Roland Ladurner in
Google Scholar
PubMed
Department of Internal Medicine III, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany
Search for other papers by Constanze Hantel in
Google Scholar
PubMed
Search for other papers by Martin Reincke in
Google Scholar
PubMed
Department of Internal Medicine III, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany
Search for other papers by Graeme Eisenhofer in
Google Scholar
PubMed
NET Unit, ENETS Centre of Excellence, Royal Free Hospital, London, UK
Search for other papers by Ashley B Grossman in
Google Scholar
PubMed
Search for other papers by Karel Pacak in
Google Scholar
PubMed
Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), Zurich, Switzerland
Search for other papers by Felix Beuschlein in
Google Scholar
PubMed
Search for other papers by Christoph J Auernhammer in
Google Scholar
PubMed
Search for other papers by Natalia S Pellegata in
Google Scholar
PubMed
Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), Zurich, Switzerland
Search for other papers by Svenja Nölting in
Google Scholar
PubMed
prospective clinical trial in PPGLs ( n = 25) reported a response rate of 13% and a disease control rate (DCR) of 83% over 3 months (DCR 61% over 6 months); allpatients with SDHx -related disease showed a partial response or stable disease ( O’Kane et al